AstraZeneca says reports Covid-19 vaccine efficacy is low in elderly are incorrect
German daily papers Handelsblatt and Bild said in separate reports on Monday the vaccine had an efficacy of 8% or less than 10%, respectively, in those over 65 and the German government did not expect the European regulator to approve the product for that age group
FILE PHOTO: The logo of AstraZeneca is seen on medication packages in a pharmacy in London, April 28, 2014. REUTERS/Stefan Wermuth/File Photo
AstraZeneca on Monday described German media reports saying its Covid-19 vaccine was shown to have a very low efficacy in the elderly as "completely incorrect".
German daily papers Handelsblatt and Bild said in separate reports on Monday the vaccine - co-developed by AstraZeneca and Oxford University - had an efficacy of 8% or less than 10%, respectively, in those over 65 and the German government did not expect the European regulator to approve the product for that age group.
